Anti-gp210 and anti-centromere antibodies for the prediction of PBC patients with an incomplete biochemical response to UDCA and bezafibrate

Hepatol Res. 2015 Aug;45(8):827-8. doi: 10.1111/hepr.12461.
No abstract available

Publication types

  • Editorial